All Stories

  1. Design, synthesis, and binding analysis of target-specific covalent inhibitors of SARS-CoV-2 papain-like protease
  2. Long QT syndrome type 1: clinical and functional characterization of KCNQ1 variant c.1111G > C
  3. Affinity and Selectivity of Protein–Ligand Recognition: A Minor Chemical Modification Changes Carbonic Anhydrase Binding Profile
  4. Reactions of Plasmodium falciparum Type II NADH: Ubiquinone Oxidoreductase with Nonphysiological Quinoidal and Nitroaromatic Oxidants
  5. Broadening the Scope of van Leusen Reaction: Investigation of Benzofuro[2,3‐d]imidazole Formation
  6. Comprehensive analysis of resorcinyl-imidazole Hsp90 inhibitor design
  7. Aortic disease and cardiomyopathy in patients with a novel DNMT3A gene variant causing Tatton-Brown–Rahman syndrome
  8. Recent advances in computational and experimental protein-ligand affinity determination techniques
  9. Biochemical and cellular insights into the Baz2B protein, a non-catalytic subunit of the chromatin remodeling complex
  10. 4H-[1,3,5,2]Oxadiazaphospholo[3,4-a][1,5]benzodiazepin-1-amine-1-oxides: Synthesis and Computational Studies
  11. Understanding the activity of glucose oxidase after exposure to organic solvents
  12. Enhanced nucleosome assembly at CpG sites containing an extended 5-methylcytosine analogue
  13. Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases
  14. Polyester Dendrimers Based on Bis-MPA for Doxorubicin Delivery
  15. Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9
  16. Structure and mechanism of secondary sulfonamide binding to carbonic anhydrases
  17. Isoform-Selective Enzyme Inhibitors by Exploring Pocket Size According to the Lock-and-Key Principle
  18. The hydrolysis of indoxyl acetate: A versatile reaction to assay carbonic anhydrase activity by high-throughput screening
  19. Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics
  20. Template‐based modeling of diverse protein interactions in CAPRI rounds 38‐45
  21. Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
  22. Engineered Carbonic Anhydrase VI-Mimic Enzyme Switched the Structure and Affinities of Inhibitors
  23. Binding affinity in drug design: experimental and computational techniques
  24. In Silico Modeling of Inhibitor Binding to Carbonic Anhydrases
  25. Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors
  26. Genome scale metabolic models as tools for drug design and personalized medicine
  27. Molecular basis for potentiation of Cx36 gap junction channel conductance by n -alcohols and general anesthetics
  28. Acetylcholine molecular arrays enable quantum information processing
  29. Predicting Isoform-specific Binding Selectivities of Benzensulfonamides Using QSAR and 3D-QSAR
  30. Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide
  31. Spintronic characteristics of self-assembled neurotransmitter acetylcholine molecular complexes enable quantum information processing in neural networks and brain
  32. COD::CIF::Parser: an error-correcting CIF parser for the Perl language
  33. CLEA-Based Immobilization of Methylotropic Yeast Alcohol Oxidase: Influence on Storage Stability and Reaction Efficiency
  34. Comparing several methods in predicting of binding affinity of ligands to carbonic anhydrase
  35. Synthesis and antiproliferative activity of α-branched α,β-unsaturated ketones in human hematological and solid cancer cell lines
  36. Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII
  37. Discovery and Characterization of Novel Selective Inhibitors of Carbonic Anhydrase IX
  38. Conformational Analysis of Processivity Clamps in Solution Demonstrates that Tertiary Structure Does Not Correlate with Protein Dynamics
  39. Monoclonal antibodies raised against 167–180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity
  40. Saccharin Sulfonamides as Inhibitors of Carbonic Anhydrases I, II, VII, XII, and XIII
  41. Design, Synthesis, Binding, Crystallography, and Docking of [(2-Pyrimidinylthio)Acetyl]Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases
  42. Insight into the role of N,N-dimethylaminoethyl methacrylate (DMAEMA) conjugation onto poly(ethylenimine): cell viability and gene transfection studies
  43. ChemInform Abstract: Design of [(2-Pyrimidinylthio)acetyl]benzenesulfonamides as Inhibitors of Human Carbonic Anhydrase.
  44. Enantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phases
  45. Structural and functional analysis of rare missense mutations in human chorionic gonadotrophin  -subunit
  46. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases
  47. Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by brownian dynamics simulations on a coarse-grained model
  48. Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance
  49. Toward the Design of Mutation-Resistant Enzyme Inhibitors: Further Evaluation of the Substrate Envelope Hypothesis
  50. Study on the cyclization of 6-arylethynylpyrimidine-5-carbaldehydes with tert-butylamine: microwave versus thermal preparation of pyrido[4,3-d]pyrimidines
  51. Quantitative Structure-Activity Relationship Models with Receptor-Dependent Descriptors for Predicting Peroxisome Proliferator-Activated Receptor Activities of Thiazolidinedione and Oxazolidinedione Derivatives
  52. HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants
  53. Erratum
  54. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease
  55. Design of Mutation-resistant HIV Protease Inhibitors with the Substrate Envelope Hypothesis
  56. SitCon: Binding site residue conservation visualization and protein sequence-to-function tool
  57. Using Protein Homology Models for Structure-Based Studies: Approaches to Model Refinement
  58. Screening Drug-Like Compounds by Docking to Homology Models:  A Systematic Study
  59. Comparing Ligand Interactions with Multiple Receptors via Serial Docking
  60. Structural model for an AxxxG-mediated dimer of surfactant-associated protein C
  61. Solution Structure and Functional Ligand Screening of HI0719, a Highly Conserved Protein from Bacteria to Humans in the YjgF/YER057c/UK114 Family † , ‡
  62. Enhanced docking with the mining minima optimizer: Acceleration and side-chain flexibility
  63. Accurate Intraprotein Electrostatics Derived from First Principles:  An Effective Fragment Potential Method Study of the Proton Affinities of Lysine 55 and Tyrosine 20 in Turkey Ovomucoid Third Domain
  64. The Effective Fragment Potential Method:  A QM-Based MM Approach to Modeling Environmental Effects in Chemistry
  65. QM/MM Boundaries Across Covalent Bonds:  A Frozen Localized Molecular Orbital-Based Approach for the Effective Fragment Potential Method
  66. Evaluation of the charge penetration energy between non-orthogonal molecular orbitals using the Spherical Gaussian Overlap approximation
  67. A quantum chemical cluster study of hydrated halide adsorption on the cathodic Al(111) surface
  68. Computation of adsorbate vibrational frequencies: methyl, methylidyne and methoxy adsorbed on the Al(111) surface
  69. Electric field effects on the geometry and vibrations of charged molecules: the hydroxide ion case
  70. Geometry Optimization of Charged Molecules in an External Electric Field Applied to F - ·H 2 O and I - ·H 2 O
  71. A theoretical investigation of adsorbate-induced surface relaxation effects using cluster models: Al on Si(111)
  72. The mechanism of electroreduction of silver cyanide complexes in aqueous electrolytes—II. Interpretation of SERS data